In a significant development for the Northern Irish health tech industry, Belfast-based Neurovalens has obtained medical device clearance from the US Food & Drug Administration (FDA) for their Modius Stress device aimed at treating anxiety.
Peruvian hospital group Auna has become Latin America’s first healthcare healthcare services company to list in the US, after its IPO on the New York Stock Exchange last week.
Last week, US health insurer giant Cigna finally offloaded its Medicare business - which manages government-back health insurance for over 65s - to insurer Health Care Service Corp (HCSC). The $3.3bn cash deal finally putting industry rumours of a megadeal with rival insurer Humana to bed.
The sale of fertility group Eugin’s has completed, with international KKR-owned fertility heavyweight IVI RMA taking over the North American side of the asset formerly owned by conglomerate Fresenius to bolster its already impressive fertility empire.
One week into the new year, and it’s already painfully clear that personnel problems persist. As a tide of industrial action by healthcare workers sweeps across the UK, HBI speaks to two market experts for their predictions about the workforce crisis going into 2024.
Capital investor Gilde Healthcare acquires a majority stake in Swiss Dental Solutions (SDS) through its private equity fund. SDS aims to accelerate its growth in both Europe and the US and become a world leader in the emerging market of ceramic dental implants.
After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
Contrary to speculation that a deal would be announced by Christmas, two of the largest health insurers in the US - Cigna and Humana - will not be merging to form a $140bn giant insurer. After reportedly failing to agree on a price, Cigna is instead reportedly planning to buy back $10bn worth of shares.
Two of the US’s largest health insurers - Cigna and Humana - are reportedly in talks to merge. A stock-and-cash megadeal could be announced by the end of the year, but any deal will likely attract the interest of the regulator.
The deconsolidation of multinational dialysis giant Fresenius Medical Care (FMC) from German health care conglomerate Fresenius Group has been completed. This means FMC is now a regular limited liability stock corporation; Fresenius Group still holds the largest minority stake (of 32.2%) in it but no longer has control over, nor unlimited liability in it.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy